Influence of the human skin tumor type in photodynamic therapy analysed by a predictive model by Salas García, Irene et al.
Hindawi Publishing Corporation
International Journal of Photoenergy
Volume 2012, Article ID 759205, 9 pages
doi:10.1155/2012/759205
Research Article
Influence of the Human Skin Tumor Type in
Photodynamic Therapy Analysed by a Predictive Model
I. Salas-Garcı́a, F. Fanjul-Vélez, and J. L. Arce-Diego
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Photodynamic Therapy (PDT) modeling allows the prediction of the treatment results depending on the lesion properties, the
photosensitizer distribution, or the optical source characteristics. We employ a predictive PDT model and apply it to different
skin tumors. It takes into account optical radiation distribution, a nonhomogeneous topical photosensitizer spatial temporal
distribution, and the time-dependent photochemical interaction. The predicted singlet oxygen molecular concentrations with
varying optical irradiance are compared and could be directly related with the necrosis area. The results show a strong dependence
on the particular lesion. This suggests the need to design optimal PDT treatment protocols adapted to the specific patient and
lesion.
1. Introduction
Photodynamic therapy is a cancer treatment modality based
on various types of photochemical interactions involving an
extrinsic chemical agent known as photosensitizer, oxygen,
and light [1]. The biological effects of localized oxidative
damage caused by PDT provoke tumor selective destruction.
PDT provides advantages over traditional techniques such
as radiation therapy or chemotherapy, like noninvasivity,
selectivity and the lack of severe collateral effects. PDT is cur-
rently applied to several tumoral tissues and it is particularly
appropriate in dermatology, due to the noncontact character
and the good cosmetic results [2]. Nonmelanoma skin cancer
is one of the most frequent malignant neoplasia in humans,
which includes basal cell carcinomas and squamous cells
carcinomas or precursor cancer diseases such as actinic
keratosis. These skin disorders have grown during the last
years due to an increase of solar exposition of the population,
the increase of the longevity, or the lack of ozone in the atmo-
sphere. Conventional techniques against these pathologies
like surgery, electrocoagulation, cryosurgery, radiotherapy,
or even pharmacological solutions present some limitations
that are successfully solved by PDT [3].
PDT in clinical praxis employs usually a fixed protocol
that is independent of the lesion and of the patient. As
a consequence some pathologies present recurrence some
time after the application of the treatment. Clinical praxis
in the Dermatology Department of Marqués de Valdecilla
University Hospital shows that the treatment response varies
with the type of pathology treated [4]. Regarding the
response of the patients to the treatment, quite good results
have been obtained without relevant side effects. These
effects are mostly heat and slight pain and they appear in the
great majority of the cases.
An optimal adjustment of the treatment is convenient,
depending on the light source and the photosensitizer
parameters, and also on the type of skin disease and the
patient. In recent years there have been different works
regarding the improvement of light delivery, the strategy
for the photosensitizer delivery, the development of new
photosensitizers, or a better oxygenation of the treated tissue
[5, 6]. The treatment adjustment requires a PDT predictive
modeling approach. There are a limited number of works
related to the development of models that characterize the
photodynamic process in order to optimize the treatment
[7]. In these studies the focus is on the development of
photochemical [8, 9] and optical propagation models [10].
Most PDT models that take into account the whole photody-
namic process usually consider a systemic application of the
photosensitizer [11], with a uniform spatial distribution in
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the target tissue. However, there are several studies that show
that in the case of a topical photosensitizer the distribution
of the drug through the skin results in an inhomogeneous
spatial pattern [12, 13]. Significant advances have been
made in the study of the photosensitizer photobleaching
and oxygen diffusion and perfusion in the tissue [14, 15].
Liu et al. [16] have recently studied singlet oxygen direct
dosimetry and photosensitizer fluorescence photobleaching
as dosimetry tools during 5-aminolevulinic acid (ALA)
induced Protophorphyrin IX (PpIX). A one-dimensional
model was proposed to simulate the dynamic process of
ALA-PDT of normal human skin in order to investigate the
time-resolved evolution of PpIX, ground state oxygen, and
singlet oxygen distributions. Although this work presents
one of the most complex models used up to now, the tissue
model employed is quite distant from a realistic clinical
application due to the fact that it is applied to normal
human skin simplified as a three-layer semi-infinite tissue.
The influence of the type of pathology in the result of PDT
treatment has been explored in several clinical studies, in
which patients exposed to PDT show different treatment
responses under the same dosimetry protocol. However, as
far as we know, treatment outcome prediction by means of a
PDT photochemical model for different skin tumors has not
been realized.
The present work is devoted to the application of a com-
plex PDT model to different types of human skin tumors.
The prediction of the PDT treatment response depending
on the particular lesion would allow the design of optimal
PDT treatment protocols adapted to the specific patient
and lesion. The PDT model used takes into account optical
radiation distribution by means of a Monte Carlo approach,
a nonhomogeneous topical photosensitizer spatial temporal
distribution, the photoactive compound synthesis and the
time-dependent photochemical interaction. The results of
the different elements’ concentrations in the photochemical
model, specially singlet oxygen production, could be directly
related with the necrosis area. The model is applied to
skin tumors, such as nodular and infiltrative basal cell
carcinomas (BCCs), or squamous cells carcinomas (SCCs).
The predicted singlet oxygen molecular concentrations of
the different tumoral skin tissues are compared with varying
optical irradiance.
The manuscript is organized as follows. Section 2 de-
scribes the PDT model employed in detail, including the
optical propagation, photosensitizer distribution, and pho-
tochemical analysis. In Section 3 the model is applied to
several skin tumors, the treatment parameters are varied,
and the predictive results are obtained. These results are
compared and discussed. The conclusions of this study are
contained in Section 4.
2. Photodynamic Therapy Model
The predictive PDT model takes into account optical radi-
ation distribution, a nonhomogeneous topical photosensi-
tizer spatial temporal distribution, and the time-dependent
photochemical interaction. Each part is described in the
following subsections.
2.1. Optical Radiation Distribution. There are different opti-
cal models to be used in biological tissues. Modeling a
biological tissue implies dealing with an heterogeneous
medium, which does not allow a analytic exact approach
of the radiation pattern with Maxwell equations. For the
problem we are dealing with, the distribution of light in a
three-dimensional tissue must be obtained. This objective
is reached by means of the Radiation Transport Theory
(RTT) [1]. The model assumes that the scattering events
are sufficiently numerous as to the light to be considered
incoherent, in such a way that polarization or interference
effects can be neglected. As a consequence, the basic
parameter of light is the specific intensity I(r, ŝ), that is, the
light power per unit area per unit solid angle. The radiation
is expected to be at point r, and to follow the direction ŝ. The
scattering events are treated according to the scattering phase
function p(ŝ · ŝ′). Optical radiation comes from direction
ŝ′ and is redirected to ŝ. The basic idea in order to write
the differential radiation transport equation is that radiation
from a particle attenuates due to absorption and scattering
and also gains power because another particle can scatter
light in the direction of the particle of interest. If there are
no sources inside the tissue and a steady-state situation, this
can be written as







p(ŝ · ŝ′)I(r, ŝ′)dΩ′.
(1)
Numerical analysis has been widely applied to a great variety
of problems governed by differential equations. In the
particular topic of the radiation transport equation, the
Monte Carlo method has demonstrated its applicability and
accuracy, compared with exact solutions. Perhaps the most
used implementation of the Monte Carlo method applied
to the RTT model is the one by Wang et al. [10, 17]. This
implementation of the Monte Carlo model is multilayered,
with their borders always perpendicular to the laser beam.
This is very useful because tissues usually can be divided in
different strata. For the appropriate definition of the model,
the characteristics and dimensions of each layer are required.
The optical parameters needed are the index of refraction n,
the absorption coefficient μa, the scattering coefficient μs, and
the anisotropy of scattering g.
2.2. Topical Photosensitizer Distribution. Methyl Aminole-
vulinate (MAL) is a prodrug that is endogenously metabo-
lized to the photoactive element Protophorphyrin IX (PpIX).
After its application on the skin surface, a diffusion process
through the different skin layers occurs and it is converted to
PpIX. Several studies have evaluated the PpIX content of the
skin using fluorescence techniques [12] and the influence of
the stratum corneum as the main barrier to the diffusion of
the photosensitizer to deeper layers of skin [13].
The inhomogeneous distribution of a topical photosen-
sitizer precursor through the skin and the photosensitizer
endogenously produced play an important role to determine
the concentration of photoactive substance to be accumu-
lated during the incubation period. For this reason we used
Fick’s law to characterize the inhomogeneous photosensitizer
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precursor distribution and to calculate the concentration
reached at each point of the tissue during the incubation
period. According to Fick’s law, if there are differences of
concentration of a substance, its molecules move from higher
to lower concentration regions, and so the flow of substance




where J is the flux vector indicating the direction and
magnitude of substance, D is the diffusion coefficient, M is
the prodrug concentration, and z is the depth in the tissue.
The distribution of the photosensitizer in the skin is
limited by several factors, including the stratum corneum
which acts as a diffusion barrier and is characterized by
the permeability, K , the diffusion coefficient through the
epidermis and dermis,D, the relaxation time of the precursor
as a consequence of the generation of the photosensitizer
and other processes (lymphatic flow and blood perfusion),
τ, and the conversion rate of photosensitizer precursor in
its photoactive compound [18]. The temporal evolution of
the photosensitizer precursor concentration for each depth




























where M0 is the concentration of photosensitizer precursor
in the skin surface at t = 0 and z is the distance from the
corneal layer located at z = 0. Once the concentration of
MAL is known at each point, the accumulated concentration
of active substance S0 in the tissue during an incubation
period of 3 hours is calculated. This lets us know the amount
of photosensitive substance at every point of the cancerous
tissue at the beginning of the radiation interval. It is assumed
that the PpIX relaxation time is fast compared to the MAL
diffusion time, τp  t, and therefore the concentration of
PpIX is proportional with the instantaneous value of MAL
concentration. This value can be calculated by means of
equation (4), where εp is the yield of the conversion process
and τa→ p the relaxation time of the photosensitizer precursor





2.3. Photochemical Interaction. Interaction of light with
a photosensitizer at an appropriate wavelength produces
an excited triplet state photosensitizer that interacts with
ground state oxygen via two types of reactions, known as
Type I and Type II. The Type II reaction is believed to be
predominant and responsible for singlet oxygen production,
which is considered as the cytotoxic element in charge of
killing carcinogenic cells.
The photochemical reactions are characterized by means
of a photochemical model [8, 9], which takes into account
the transitions between states of the particles involved, such
as the photosensitizer and oxygen. The solutions of the stiff
differential equations system employed, (5), are obtained by
means of a differential equation solver within the Matlab
platform. In order to obtain coherent results, we had to
adjust relative and absolute error tolerances. These solutions
provide the temporal evolution of the different molecular
concentrations of the compounds involved in a Type II

































































































In these equations, [S0] is the concentration of the photo-
sensitizer in ground state, [S1] is the concentration of the
photosensitizer in singlet excited state; [T] is the concen-
tration of photosensitizer in triplet excited state; [ 3O2] is
the concentration of oxygen in ground state; [ 1O2] is the
concentration of singlet oxygen; [R] is the concentration of
singlet oxygen receptors; [C]i is the scavengers concentra-
tion; τ1 is the relaxation time from state S1 to S0; τ3 is
the relaxation time from state T to S0; τ0 is the relaxation
time from state 1O2 to
3O2; η10 is the quantum yield of the
transition from state S1 to S0; η13 is the quantum yield of
the transition from S1 to T ; η30 is the quantum yield of T
transition to S0; η0 is the quantum yield of
1O2 transition
to 3O2; αs is the efficiency factor for energy transfer from
T to 3O2; kpb stands for the biomolecular photobleaching
rate; kcx is the biomolecular cytotoxicity rate; ksc is the rate
of reaction of 1O2 with various oxygen scavengers; ν is light
speed in tissue; ρ is the photon density present at a point;
σpsa is the absorption cross-section of S0 molecules; P is the
rate of oxygen diffusion and perfusion; U is the cell damage
repair rate.
3. Results and Discussion
The optical radiation distribution was obtained by means of
the Monte Carlo method presented in the previous section. A
cylindrical laser beam with a radius of 0.3 cm perpendicular
to the tissue sample was used to deliver different irradiances
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Table 1: Optical parameters used for each layer of the tissue sample
model (λ = 633 nm) and depth.
Layer n μa (cm−1) μs (cm−1) g Depth (cm)
SCC 1.5 2 95.238 0.79 0.3
Nodular BCC 1.5 1.5 104.76 0.79 0.3
Infiltrative BCC 1.5 1.5 142.85 0.79 0.3
Muscle 1.37
Table 2: Total energy (J) in the three skin pathology samples for
different irradiances.
Irradiance (W/cm2) 100 150 200
Nodular BCC 0.0221 0.0333 0.0443
Infiltrative BCC 0.0197 0.0297 0.0394
SCC 0.0239 0.0358 0.0477
(100, 150, and 200 mW/cm2). The radiation time was 10
minutes. The tissue model is composed of two layers, the
upper one was corresponding to the tumor zone and the
other below was considered muscle. The optical parameters
corresponding to the three skin pathologies are listed in
Table 1 [19, 20].
Figure 1 displays the optical absorption (J/cm3) in three
types of human skin tumors (nodular BCC, infiltrative BCC,
and SSC) for the illumination conditions previously showed.
As it can be observed optical absorption varies depending
on the type of pathology and anatomical position in the
tissue sample. In deeper tumor positions optical absorption
is lower than in superficial zones and so the photon density
that will excite the ground state photosensitizer diminishes
with depth. Larger power densities induce larger absorption
in all the pathologies.
The tumor optical properties affect final optical dis-
tribution and make optical energy vary depending on the
biological media. The total energy in the whole tissue model
was calculated for the three types of tumor. The results are
listed in Table 2, where it can be observed that an infiltrative
BCC accumulates less energy than the other two types of
skin pathologies for all the irradiances applied to the tumor
surface. The SCC tumor presents larger energy accumulation
than the others.
The spatial and temporal diffusion of a topical photosen-
sitizer precursor in the tissue sample and the photosensitizer
endogenously produced were obtained during an incuba-
tion period of three hours. The corneal layer reduces the
permeability of the skin, so that its value can be adjusted
to characterize different skin conditions. In this case it is
damaged or reduced by the skin lesion corneal layer. As a
consequence, the value of permeability, K = 10−6 m/s, was
chosen greater than that in the case of healthy skin with
an intact cornea [18]. The diffusion coefficient through the
epidermis and dermis was 0.69·10−10 m2/s, the relaxation
time of the prodrug 24 hours, the yield of the conversion
process 0.5, the relaxation time of the photosensitizer
84 ms, and the relaxation time of the precursor due to the
generation of the photosensitizer 25 hours [18, 21]. The
clinical Metvix-PDT protocol only specifies that Metvix is
applied in a 1 mm thick layer on the affected area covering an
extra 5 mm of healthy skin around the damaged area and has
an incubation period of 3 hours before radiation. Therefore
in order to estimate the concentration of the PpIX precursor
applied on the skin tumor as close as possible to a real
case, we have taken into account the area of the pathology
and MAL density per gram of Metvix cream. Assuming a
circular lesion of radius 1 cm, a MAL density of 160 mg per
gram of Metvix cream, and the molecular mass of MAL, we
calculated a MAL concentration on the pathology surface of
4.5031·1020 cm−3.
The results are presented in Figure 2. As it can be ob-
served, the barrier blocks the diffusion to deeper layers
during the first part of the photosensitizer incubation pro-
cess. This phenomenon causes an uneven distribution
of the photosensitizer in the skin during the period of
incubation. The initial photosensitizer concentration when
the optical irradiation starts will not be the same at every
point of the tissue. Therefore there will be differences in
the results of the photodynamic procedure. This is an
important aspect to consider when dealing with a topical
photosensitizer precursor, since in the case of a systemic
photosensitizer a homogeneous distribution is generally
considered. The photosensitizer concentration three hours
after its administration was used as an initial condition to
the photochemical model, which calculates the temporal
evolution of the molecular components involved in the
photochemical reactions by means of the stiff differential
equations system previously shown.
Typical clinical conditions for the photosensitizer Metvix
for PDT were considered in this study. Literature related to
well-known photosensitizers of the porphyrins family was
employed to assign the parameters values when they were
not available for this photosensitizer [6]. The absorption
cross-section of PpIX molecules (σpsa = 0.37·10−15 cm2) at
the treatment wavelength was derived from a study of the
cellular photosensitizing properties of PpIX carried out in a
transformed murine keratinocyte cell line [22]. Due to the
fact that MAL is a derivative of 5-aminolevulinic acid, the
relaxation time from singlet excited state to ground state S1
to S0 was set to 7.4 ns as reported earlier from fluorescence
measurements in cells incubated with 5-aminolevulinic acid
induced PpIX [23]. The triplet state lifetime in vivo in
skin (τ3) was set to 26 μs and the relaxation time of 1O2
to 3O2 to 0.04 μs [24]. Quantum yield transitions between
different energetic states were adopted to be similar to
those previously considered for the photosensitizer Photofrin
η10 = 0.2, η30 = 0.3, η0 = 0.3, and η13 = 0.8 as well as
biomolecular photobleaching, cytotoxicity, and scavenging
rates that were set to 2·10−10 cm3/s−1, 2·10−9 cm3/s−1,
and 1·10−9 cm3/s−1, respectively [9]. At the beginning of
the optical irradiation period there are not molecules of
photosensitizer in excited state; so the initial concentrations
of S1 and T are 0 cm−3. In the same way singlet oxygen
molecules have not yet been produced and their initial
concentration is 0 cm−3. The tissue sample was considered
homogeneously oxygenated with an initial concentration of
cellular oxygen of 5·1017 cm−3 and diffusion and perfusion
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Figure 1: Optical absorption (J/cm3) for nodular BCC tumor: (a) 100 mW/cm2, (b) 150 mW/cm2 (c) 200 mW/cm2; infiltrative BCC: (d)
100 mW/cm2: (e) 150 mW/cm2, (f) 200 mW/cm2; SCC tumor: (g) 100 mW/cm2, (h) 150 mW/cm2, (i) 200 mW/cm2.
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Figure 2: Spatial-temporal distribution of a topical photosensitizer.
rates of 1·1012 cm−3·s−1 [9]. Initial concentration of intra-
cellular molecular singlet oxygen receptors was 5·1017 cm−3
scavenger concentration was 1·103 cm−3, and cell damage
repair rate was 2.6·1012 cm−3·s−1 [9].
The temporal evolution of the photosensitizer at differ-
ent energetic states, oxygen, and singlet oxygen molecular
concentrations was obtained by means of the photochemical
model for the three different skin tumors and varying optical
irradiance. The concentrations of ground state molecules of
photosensitizer, oxygen in ground state, and receptors vary
slowly in response to the activation light. While applying
optical radiation, the concentrations of the triplet state
molecules of photosensitizer and singlet oxygen in all the
tissue samples begin to increase slowly until they reach a
maximum value.
Different maximum singlet oxygen concentrations were
reached for different types of skin pathologies and depths;
so different treatment outcomes could be expected. Figure 3
shows the maximum singlet oxygen concentration reached
at every point of the tissue sample, depending on the
target anatomical position. The spatial variation is presented
according to the depth from the tissue surface and the
distance to the center of the laser beam.
It can be observed for all the pathologies that an irradi-
ance increment induces a larger amount of singlet oxygen in
the target tissue. However, this amount is not the same in all
of them. Figure 4 shows that the pathology which accumu-
lates a larger singlet oxygen concentration depends on the
observation depth from the tumor surface. At the maximum
tumor depth of 3 mm singlet oxygen produced is larger in
the nodular BCC (2.746·104, 4.204·104, and 5.651·104 cm−3
for 100, 150, and 200 mW/cm2, resp.) than that in the other
















































































































































































































Figure 3: Maximum singlet oxygen concentration (cm−3) in nodular BCC tumor: (a) 100 mW/cm2, (b) 150 mW/cm2, (c) 200 mW/cm2; in
infiltrative BCC tumor: (d) 100 mW/cm2, (e) 150 mW/cm2, (f) 200 mW/cm2; in SCC: (g) 100 mW/cm2, (h) 150 mW/cm2, (i) 200 mW/cm2.
two pathologies independently of the applied irradiance (see
Figures 4(a)–4(c)), whereas the pathology which accumu-
lates the lowest maximum singlet oxygen concentration is
infiltrative BCC (1.731·104, 2.654·104, and 3.531·104 cm−3
for 100, 150, and 200 mW/cm2, resp.). However when
the observation depth is more superficial, 0.1 mm from
the tumor surface (Figures 4(d)–4(f)), infiltrative BCC
presents the largest maximum singlet oxygen concentration
(7.229·108, 1.091·109, and 1.428·109 cm−3 for 100, 150,
and 200 mW/cm2, resp.) and SCC the lowest (5.673·108,
8.459·108 and 1.118·109 cm−3 for 100, 150 and 200 mW/cm2
resp.). The variation in singlet oxygen production at different
depths when comparing the lesions is caused essentially by
the particular optical radiation distribution in each case. As
some pathologies accumulate preferentially optical radiation
at lower depths, the singlet oxygen production is lower
deeper in the tissue, where energy absorption is smaller.
In Figures 4(d)–4(f) a clear influence of the optical
beam radius in the maximum singlet oxygen concentration
accumulated in the target tissue can be observed. The most
superficial tissue zone shows a significant singlet oxygen
concentration decrease as the measurement point gets far
from the laser beam impact center. Differences in the
maximum amount of singlet oxygen molecules generated in
the volume occupied by the tumor can also be observed.
They vary depending on both irradiance and type of
tumor, as it is shown in Table 3. For a fixed irradiance,
the amount of singlet oxygen molecules in the volume
occupied by the tumor varies depending on the type of
pathology. It is maximum in the infiltrative BCC tumor
(1.1995·107, 1.8165·107 and 2.4246·107 molecules of 1O2
for 100, 150 and 200 mW/cm2 resp.) and minimum in the
SCC (9.9338·106, 1.5072·107 and 2.0199·107 molecules of
1O2 for 100, 150 and 200 mW/cm2 resp.).
When comparing Tables 2 and 3, it can be seen that the
total optical energy absorbed by the tumor is not propor-
tionally related with the total singlet oxygen molecules. For
instance, SCC presents a higher value of total optical energy,
but the lowest number of total singlet oxygen molecules.
This effect is related with the nonlinear character of the
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Figure 4: Maximum singlet oxygen concentration at the deepest position in the tumor (3 mm) versus distance to the center of the
illumination spot for different irradiances: (a) 100 W/cm2, (b) 150 W/cm2, and (c) 200 W/cm2 in all the pathologies (BCC: nodular basal cell
carcinoma; INF: infiltrative basal cell carcinoma; SCC: squamous cell carcinoma) and at 0.1 mm from the pathology surface and different
irradiances: (d) 100 W/cm2, (e) 150 W/cm2, and (f) 200 W/cm2.
Table 3: Maximum amount of singlet oxygen molecules in the tu-
mor volume.
Irradiance (W/cm2) 100 150 200
Nodular BCC 1.1651·107 1.7695·107 2.3644·107
Infiltrative BCC 1.1995·107 1.8165·107 2.4246·107
SCC 9.9338·106 1.5072·107 2.0199·107
photochemical process. As optical energy is bigger at a
specific point, singlet oxygen production efficiency decreases.
Optical energy is preferentially accumulated in the superficial
layers of the SCC (see Figure 1), and so deeper layers
present lower-energy absorption. This makes the whole
singlet oxygen production efficiency decrease.
All the results previously shown indicate that the treat-
ment effect, which is closely related to the amount of
singlet oxygen produced, varies depending on the type of
tumor we are dealing with. Therefore the type of pathology
should be taken into account to adjust the irradiation
source parameters, such as the optical laser beam radius and
the irradiance applied to the pathology surface to obtain
the maximum cancerous tissue necrosis. This approach
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would serve to predict the damage induced in the types of
pathologies studied if a precise singlet oxygen threshold was
established as the amount necessary to induce cell toxicity in
each case.
4. Conclusions
Rigid protocols employed in PDT, which are independent of
the particular lesion and the patient, were shown to com-
promise the treatment efficiency according to clinical studies.
These studies identify different treatment responses and the
recurrence of the skin disorders as the main inconvenient
of PDT. In order to remove this problem the adjustment of
all the parameters involved in the photochemical reactions
is proposed, as a function of the type of skin disease. This
adjustment was analyzed by means of a complex predictive
PDT model.
The PDT model employed takes into account optical
radiation distribution, a nonhomogeneous topical photosen-
sitizer spatial-temporal distribution, and the time-dependent
photochemical interaction. The results obtained in the
present work show a clear influence of the type of skin tumor
under treatment in the effect of photochemical reactions
induced in PDT, specifically in the amount of reactive
oxygen produced. Under the same illumination conditions
and assuming the same photosensitizer distribution for the
three types of skin tumors modeled (nodular BCC, SSC, and
infiltrative BCC), differences in the maximum amount of
singlet oxygen molecules accumulated in the tumoral region
were observed, depending on the type of pathology. These
differences induce different treatment responses, because
the amount of reactive oxygen molecules is related to
cell destruction processes and necrosis. Therefore it was
demonstrated that treatment outcome also depends on the
type of pathology. As a consequence actual clinical protocols
should be adjusted taking into account factors related to the
type and morphology of the tumor we are dealing with.
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